Concepedia

Richard A. Ruberto

RA

Statistics

Publications

5

Citations

641

H-Index

5

Active since

2018

Affiliations

Broad Institute(Current)

Harvard University

Bayer (Germany)

Richard A. Ruberto is an author at Broad Institute specializing in drug discovery, medicinal chemistry, and targeted covalent inhibitors.

ORCID

Publications per year

2018–2022

5

Publications

5

Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles

John K. Eaton, Laura Furst, Richard A. Ruberto et al. · Nature Chemical Biology · 2020 · 472 citations · Full text

, , +6

Diacylfuroxans Are Masked Nitrile Oxides That Inhibit GPX4 Covalently

John K. Eaton, Richard A. Ruberto, Anneke Kramm et al. · Journal of the American Chemical Society · 2019 · 120 citations · Full text

, , +11

Modulation of ferroptosis sensitivity by TXNRD1 in pancreatic cancer cells

Luke L. Cai, Richard A. Ruberto, Matthew J. Ryan et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 17 citations · Full text

, , +17

Targeting a Therapy-Resistant Cancer Cell State Using Masked Electrophiles as GPX4 Inhibitors

John K. Eaton, Laura Furst, Richard A. Ruberto et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2018 · 16 citations · Full text

, , +14

Disparities in Telemedicine Utilization During COVID-19 Pandemic

Richard A. Ruberto, Eric A. Schweppe, Rifat Ahmed et al. · JBJS Open Access · 2022 · 16 citations · Full text

, , +9

1–5 of 5